XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Net Sales $ 20,612 $ 20,338
Cost of Products Sold 10,846 10,365
Selling, General and Administrative Expense 4,827 4,950
Operating Income 4,939 5,023
Interest Expense (123) (109)
Interest Income 42 11
Other Non-operating Income/(Loss), Net 139 110
Earnings/(Loss) from Continuing Operations Before Income Taxes 4,997 5,035
Income Taxes on Continuing Operations 1,034 909
Net Earnings 3,963 4,126
Net Income (Loss) Attributable to Noncontrolling Interest 24 14
Net Income (Loss) Attributable to Parent $ 3,939 $ 4,112
Basic Net Earnings Per Common Share    
Basic Net Earnings/(Loss) Per Common Share [1],[2] $ 1.62 $ 1.66
Diluted Net Earnings Per Common Share    
Diluted Net Earnings/(Loss) Per Common Share [1],[2] $ 1.57 $ 1.61
Diluted Weighted Average Common Shares Outstanding 2,503.6 2,558.9
[1] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[2] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.